Advances in Immunotherapy for Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Boyuan, Zhang, Hongbo, Gu, Lijuan, Ye, Bainxin, Jian, Zhihong, Stary, Creed, Xiong, Xiaoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337363/
https://www.ncbi.nlm.nih.gov/pubmed/28299344
http://dx.doi.org/10.1155/2017/3597613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337363/
https://www.ncbi.nlm.nih.gov/pubmed/28299344
http://dx.doi.org/10.1155/2017/3597613

Ejemplares similares